LON:CNSL Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis GBX 2.70 0.00 (0.00%) As of 12:17 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Cambridge Nutritional Sciences Stock (LON:CNSL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CNSL alerts:Sign Up Key Stats Today's Range 2.55▼ 2.7050-Day Range 2.52▼ 3.3052-Week Range 2.50▼ 4.48Volume385,061 shsAverage Volume349,661 shsMarket Capitalization£6.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.Read More… Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address CNSL Stock News HeadlinesCambridge Nutritional Sciences Faces Historical Legal ChallengeJanuary 21, 2025 | tipranks.comCambridge Nutritional Sciences Resolves Legal Dispute with DHSCJanuary 16, 2025 | tipranks.comSee More Headlines CNSL Stock Analysis - Frequently Asked Questions How have CNSL shares performed this year? Cambridge Nutritional Sciences' stock was trading at GBX 2.80 at the beginning of the year. Since then, CNSL stock has decreased by 3.5% and is now trading at GBX 2.70. View the best growth stocks for 2025 here. How were Cambridge Nutritional Sciences' earnings last quarter? Cambridge Nutritional Sciences plc (LON:CNSL) posted its quarterly earnings data on Thursday, November, 21st. The company reported ($0.10) EPS for the quarter. Cambridge Nutritional Sciences had a negative trailing twelve-month return on equity of 3.34% and a negative net margin of 3.36%. How do I buy shares of Cambridge Nutritional Sciences? Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings11/21/2024Today5/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryCommunication Current SymbolLON:CNSL CIKN/A Webwww.cnsplc.com Phone(217) 235-3311FaxN/AEmployees3,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio73.24 P/E GrowthN/ANet Income£-3,030,000.00 Net Margins-3.36% Pretax MarginN/A Return on Equity-3.34% Return on Assets-2.36% Debt Debt-to-Equity Ratio1.53 Current Ratio4.67 Quick RatioN/A Sales & Book Value Annual Sales£9.77 million Price / Sales0.66 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 4 per share Price / Book0.68Miscellaneous Outstanding Shares237,950,000Free FloatN/AMarket Cap£6.42 million OptionableN/A Beta3.89 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (LON:CNSL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.